Alturkustani Murad, Keith Julia, Hazrati Lili-Naz, Rademakers Rosa, Ang Lee-Cyn
From the London Health Sciences Center (MA, L-CA) and Western University (MA, L-CA), London; and Sunnybrook Health Sciences Center, University of Toronto (JK), and Tanz Center for Research in Neurodegenerative Diseases (L-NH), Toronto, Ontario, Canada; Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida (RR); and Department of Pathology, King Abdulaziz University and Hospital, Jeddah, Saudi Arabia (MA).
J Neuropathol Exp Neurol. 2015 Mar;74(3):233-40. doi: 10.1097/NEN.0000000000000168.
The pathologic features of adult-onset leukoencephalopathy/leukodystrophy with axonal spheroids (ALAS) are variable, and this has led to different hypotheses as to whether primarily demyelination or axonopathy may underlie this disorder. Typical ALAS pathology is rarely accompanied by focal multiple sclerosis (MS)-like plaques. In ALAS pathology accompanied by focal multiple sclerosis (MS)-like plaques cases, the pathologic features cannot be distinguished from those of progressive MS with diffusely abnormal white matter. To clarify these issues, we examined neuropathologic features in 159 representative samples from 5 ALAS cases (3 men and 2 women aged 39-61 years) and in 95 representative samples from 3 chronic MS cases (1 man and 2 women aged 50-73 years). The white matter abnormalities in ALAS cases were characterized by 3 evolving stages: 1) white matter with numerous spheroids in a background of well-myelinated fibers; 2) moderate loss of myelinated fibers with sparse to moderate number of spheroids; and 3) leukodystrophy-like pattern of confluent axonal and myelin loss. The application of this staging system suggests that myelin loss in ALAS is preceded by axonopathy. In progressive MS cases, the diffusely abnormal white matter pathology could be attributed to both primary demyelination and axonopathy. Some cases with predominant axonopathy are difficult to distinguish from cases with ALAS.
成人起病的伴有轴突球状体的白质脑病/脑白质营养不良(ALAS)的病理特征各异,这引发了关于该疾病主要是脱髓鞘还是轴索性病变的不同假说。典型的ALAS病理很少伴有局灶性多发性硬化(MS)样斑块。在伴有局灶性MS样斑块的ALAS病理病例中,其病理特征无法与弥漫性白质异常的进展性MS相区分。为阐明这些问题,我们检查了来自5例ALAS病例(3名男性和2名女性,年龄39 - 61岁)的159个代表性样本以及来自3例慢性MS病例(1名男性和2名女性,年龄50 - 73岁)的95个代表性样本的神经病理特征。ALAS病例中的白质异常具有3个演变阶段:1)在髓鞘化良好的纤维背景中有大量球状体的白质;2)髓鞘化纤维中度丢失,球状体数量稀疏至中等;3)融合性轴突和髓鞘丢失的脑白质营养不良样模式。这种分期系统的应用表明,ALAS中的髓鞘丢失先于轴索性病变。在进展性MS病例中,弥漫性异常的白质病理可归因于原发性脱髓鞘和轴索性病变。一些以轴索性病变为主的病例难以与ALAS病例区分开来。